Apollomics (APLMW) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.01, +7.92% vs the prior close of $0.01.
- Volume 6.05K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
APLMW jumps 7.9% to $0.01. Closed at $0.01, +7.92% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.02.
APLMW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — APLMW jumps 7.9% to $0.01
- Closed at $0.01, +7.92% vs the prior close of $0.01. Day range $0.01–$0.01, opened at $0.02.
- Volume was 6.05K shares, 1.5x its 50-day average of 3.95K.
- 52-week range $0.01–$0.01; today's close sits at 47% of that range, 7.6% below the 52-week high.
APLMW bull case vs bear case (from the data)
- Insiders made 20 open-market purchases in the last 12 months.
- High volatility: average daily move of 7.9% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
APLMW latest news & SEC filings
Every SEC filing by or about APLMW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Chen Yi-Kuei converted options/RSUs into 5,000 shares on Sep 15, 2026; now holds 20,100
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Lin Peter Kuan-How converted options/RSUs into 10,000 shares on Sep 15, 2026; now holds 58,979
- Lin Peter Kuan-How had withheld for taxes 3,416 shares at $24.02 (≈$82.05K) on Sep 15, 2026; now holds 55,563
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Yen Hung Hsien converted options/RSUs into 500 shares on Sep 15, 2026; now holds 500
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lin Peter Kuan-How converted options/RSUs into 10,000 shares on Sep 15, 2026; now holds 58,979
- Lin Peter Kuan-How had withheld for taxes 3,416 shares at $24.02 (≈$82.05K) on Sep 15, 2026; now holds 55,563
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chen Hong-Jung converted options/RSUs into 500 shares on Sep 15, 2026; now holds 4,120
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chen Yi-Kuei converted options/RSUs into 5,000 shares on Sep 15, 2026; now holds 20,100
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade APLMW
- How much it moves: over the last 20 sessions the average daily move was 7.92% (largest 7.9%). That is a volatile stock.
- Liquidity: about 5.00K shares (≈$55) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.01 vs a range of $0.01–$0.01 (47% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Hung-Wen Chen bought 266,667 shares on Aug 14, 2026.
- Latest filings: 6-K Aug 12, 2026; 6-K Jul 21, 2026; 6-K Jul 14, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
APLMW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.02 | 0.01 | 0.01 | 0.01 | 6.05K |
| Oct 16, 2026 | 0.02 | 0.01 | 0.01 | 0.01 | 3.95K |
About Apollomics
Apollomics (APLMW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in COVINA, CA. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1944885.
APLMW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Hong-Jung Chen | Director | Sep 17, 2026 |
| Yi-An Chu | Director | Jun 16, 2026 |
| Hung-Wen Chen | Chief Executive Officer | Sep 17, 2026 |
| Yi-Kuei Chen | Chief Operating Officer | Sep 24, 2026 |
| Ya-Chi Huang | Director | Sep 17, 2026 |
| Chen-Huan Jan | Director | Jun 16, 2026 |
| Hsien-Shu Tsai | Director | Sep 17, 2026 |
| Hung Hsien Yen | Director | Sep 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hung-Wen Chen | Chief Executive Officer | Sep 17, 2026 |
| Yi-Kuei Chen | Chief Operating Officer | Sep 24, 2026 |
| Peter Kuan-How Lin | Chief Financial Officer | Sep 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2026 | Hung-Wen Chen | Buy | 266,667 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 166,667 | $12.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 103,333 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 266,667 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 166,667 | $12.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 103,333 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 266,667 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 166,667 | $12.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 103,333 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 266,667 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 166,667 | $12.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 103,333 | $15.00 |
| Aug 14, 2026 | Yi-Kuei Chen | Buy | 20,000 | $15.00 |
| Aug 14, 2026 | Yi-Kuei Chen | Buy | 20,000 | $15.00 |
| Aug 14, 2026 | Yi-Kuei Chen | Buy | 20,000 | $15.00 |
APLMW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
APLMW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on APLMW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.